IFIH1 is overexpressed in several topotecan-resistant ovarian cancer cell lines; thus, the gene might participate in the drug resistance mechanism of the tumor (Klejewski et al., 2017). The gene discussed is IFIH1; the disease is ovarian carcinoma.